University of New Mexico
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of New Mexico sits in the top decile of US sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count).
University of New Mexico: 168 sponsored US clinical trials, 2 recruiting.
University of New Mexico sponsors 168 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 123 completed. 15 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
University of New Mexico ranks in the top decile of sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
123 of 165 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
168 total, page 3 of 4
DBRCT on the Effect of Grip Strength in Brachial Plexus vs Distal Forearm Nerve Blocks
NCT01927289
Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
NCT01804777
Standard Versus Mnemonic Counseling for Fecal Incontinence
NCT01778660
A Prospective Trial of Ayurveda for Coronary Artery Disease
NCT02228343
The Effects of the STAR Maneuver on UGRA Training
NCT02032420
Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF
NCT01303068
Nitrous Oxide for Pain Management of First Trimester Surgical Abortion
NCT02096575
Trial on the Effects of Ultrasound Probe Position on Ultrasound-guided Nerve Blocks
NCT01690156
Does Ultrasound Improve Procedural Time in the Lateral Popliteal Approach to the Sciatic Nerve in Obese Patients
NCT01579747
Cycling Versus Continuous Mode in Neuromodulator Programming
NCT02551822
Impact of Ranolazine on Coronary Microcirculatory Resistance
NCT01815957
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
NCT01764451
DASH - Decision Making in Adolescent Sexual Health
NCT02141646
Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
NCT01534494
A Nutrition/Hygiene Education Program for the Prevention of Child Malnutrition in Rural Kenya
NCT01679535
Blood Pressure in Dialysis Patients
NCT01421771
Efficacy Study of Mindfulness-Based Exercise for Posttraumatic Stress Disorder (PTSD)
NCT01462045
Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time
NCT01567852
Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)
NCT01497756
Minimum Effective Concentration of Ropivacaine for Brachial Plexus Block Via the Supraclavicular and Infraclavicular Approach, Femoral Nerve Block, Sciatic Nerve Block Via the Popliteal and Parasacral Approach
NCT01452126
Commerical DHA Supplementation
NCT05415293
Alcohol, Marijuana, and Risky Sex: Group Interventions With Detained Adolescents
NCT01170260
Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin
NCT01207778
Assessing the Fit of Motivational Interviewing by Cultures With Adolescents
NCT01948700
Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis
NCT01471457
Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder
NCT00721526
Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture
NCT01719237
Timing of Insulin Before Meals Everyday
NCT00789945
Adolescents Committed to Nutrition and Physical Activity
NCT00841334
Caffeine Reduction and Overactive Bladder Symptoms
NCT00754260
Synchronized Intermittent Mechanical Ventilation Versus Open Lung Ventilation With Spontaneous Respiration
NCT00891085
Prevention of Post Operative Bone Loss in Children
NCT00655681
Comparative Trial Between 3 Types of Insulin Infusion Protocols
NCT00582309
INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
NCT00322712
Darbepoetin Administration to Preterm Infants
NCT00334737
Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer
NCT00322751
Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants
NCT01235923
Child Health Initiative for Lifelong Eating and Exercise (CHILE)
NCT00428805
Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review
NCT00322725
Vitamin C and Cardiovascular Risk
NCT00534014
Exercise Induced Bronchospasm in Children
NCT00273689
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
NCT00320918
12-step Facilitation for the Dually Diagnosed
NCT00583440
Immune Dysfunction in Allergic Asthma
NCT00189228
Microalbuminuria in Children With and Without Diabetes
NCT00320086
Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting
NCT00322647
Reciprocating Medical Devices - a Study of a New Safety Device
NCT00651625
Mediators and Moderators of Exercise Behavior Change
NCT01091857
Vitamins C and Vitamin E and Cardiovascular Risk
NCT00362518
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
NCT00250055
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 11 |
| Phase 3 | 4 |
| Phase 4 | 11 |
What is open in the University of New Mexico pipeline
2 recruiting of 168 indexed (1% open); 123 completed (73%).
Phase mix: 15 late (III/IV) vs 25 early (I/II) (early-phase heavy).
Therapeutic area indexing for this sponsor is limited in the public registry.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of New Mexico: open-pipeline peers nationwide
Peers matched on 168 registered trials and 1% open enrollment, not the therapeutic-area sidebar.
University of New Mexico sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 168 trials (± recruiting share)
- Astellas Pharma Global Development · 168 trials · 11% recruiting
- Bausch Health Americas · 168 trials · 4% recruiting
- Seattle Children's Hospital · 168 trials · 17% recruiting
- Sumitomo Pharma America · 168 trials · 4% recruiting
Sponsors near 1% open enrollment (± trial volume)
- Astellas Pharma · 1% recruiting · 165 trials
- Abbott Nutrition · 1% recruiting · 89 trials
- Baxalta now part of Shire · 1% recruiting · 74 trials
- Power Life Sciences · 2% recruiting · 62 trials
Related
What to do with this University of New Mexico page
168 registered trials is a research-attention snapshot, not an endorsement of University of New Mexico or any single study.
- 2 of University of New Mexico's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of New Mexico pipeline card: 168 registered trials from official public datasets.Report a data error.